Collectively, these results suggested that, GRP75 activated XIAP, which inhibited the activations of caspase-9, and further down-regulated caspase-3, together enhanced the anti-apoptosis ability, finally leading to the acquirement and maintenance of MDR properties in HCC cells. The gene discussed is HSPA9; the disease is hepatocellular carcinoma.